A Note on Peptides by Shantanu Out of Singapore FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of BPC 157 Prosperxlabs When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA UPDATED PEPTIDES APRIL 15, 2026 Most people are already getting this wrong. Today, the FDA updated its 503A compounding categories and removed several peptides from the high risk (Category 2)